RG7204
Term · Oncology and biomedicine · MLC-T-ONC-007427
A drug used to treat Erdheim-Chester disease (a very rare type of histiocytosis) and advanced melanoma that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. RG7204 blocks certain proteins made by the mutated BRAF gene, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, vemurafenib, and Zelboraf.
| Identifier | MLC-T-ONC-007427 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | BRAF (V600E) kinase inhibitor RO5185426; vemurafenib; Zelboraf |
| Synonyms | PLX4032 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007427",
"term": "RG7204",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat Erdheim-Chester disease (a very rare type of histiocytosis) and advanced melanoma that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. RG7204 blocks certain proteins made by the mutated BRAF gene, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, vemurafenib, and Zelboraf.",
"expansions": [
"BRAF (V600E) kinase inhibitor RO5185426",
"vemurafenib",
"Zelboraf"
],
"synonyms": [
"PLX4032"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/rg7204/"
}
Record 14,441 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.